Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management: Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting

Introduction Chemotherapy-induced nausea and vomiting remains a significant problem for cancer patients. Discussion Patient factors such as polypharmacy, medication costs, mucositis, and depression may hinder good antiemetic control, while high workloads, poor communication, and underestimation of t...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2010-03, Vol.18 (Suppl 1), p.1-10
Main Authors: Grunberg, Steven, Clark-Snow, Rebecca A., Koeller, Jim
Format: Article
Language:English
Subjects:
Antiemetics
Antiemetics - adverse effects
Antiemetics - therapeutic use
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Bone marrow
Cancer
Cancer therapies
Care and treatment
Chemotherapy
Dopamine
Drug dosages
Hair loss
Humans
Medical personnel
Medicine
Medicine & Public Health
Meeting Highlights
Mucositis
Nausea
Nausea - chemically induced
Nausea - drug therapy
Neoplasms - drug therapy
Nurses
Nursing
Nursing Research
Oncology
Pain Medicine
Patients
Physicians
Polypharmacy
Prescription drugs
Rehabilitation Medicine
Risk Factors
Testicular cancer
Transplants & implants
Vomiting
Vomiting - chemically induced
Vomiting - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Chemotherapy-induced nausea and vomiting remains a significant problem for cancer patients. Discussion Patient factors such as polypharmacy, medication costs, mucositis, and depression may hinder good antiemetic control, while high workloads, poor communication, and underestimation of the problem on the part of healthcare professionals also play a role. Improving outcomes requires accurate assessment of risk factors, use of guidelines, and better adherence to antiemetic regimens. Conclusion Extended-release formulations and new delivery systems such as transdermal patches, nasal sprays, and pumps provide a new strategy that may improve patient outcomes.
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-009-0807-z